| CPC G16B 15/00 (2019.02) [C07K 16/00 (2013.01); G01N 33/531 (2013.01); G16B 35/00 (2019.02); G16B 35/20 (2019.02); G16C 20/60 (2019.02); C07K 2317/10 (2013.01)] | 26 Claims |

|
1. A computer-implemented method comprising:
obtaining a clearance rate criterion for an antibody;
calculating a net charge using a light chain variable domain (VL) amino acid sequence and a heavy chain variable domain (VH) amino acid sequence of the antibody;
determining the net charge is within a specific net charge range;
calculating, using a molecular dynamics (MD) simulation, a hydrophobicity from one or more complementarity determining regions (CDRs) of the antibody;
determining the hydrophobicity is within a hydrophobicity range;
determining that the antibody has a predicted clearance rate that is below or equal to the clearance rate criterion;
determining that the antibody is suitable for inclusion in a pharmaceutical product; and
manufacturing the antibody and/or the pharmaceutical product comprising the antibody, wherein the manufactured antibody comprises: (i) the net charge being within the specific net charge range, (ii) the hydrophobicity being within the hydrophobicity range, and (iii) the predicted clearance rate being below or equal to the clearance rate criterion.
|